|
| |
| Business Focus: |
| Renal Care |
|
| Stock Ticker: |
| FMS |
| Company Description: |
| Fresenius Medical Services operates more than 1,700 outpatient dialysis clinics in the U.S. Its Renal Therapies Group is responsible for the manufacture and distribution of a variety of dialysis products and equipment, including dialysis machines, dialyzers and other dialysis-related supplies. Fresenius Medical Services provides the highest quality standards in dialysis care and products in the industry to meet the needs of our patients and affiliated physicians. |
| |
| Company Ownership: |
Renaissance Health Care, Inc. is a wholly owned subsidiary of Fresenius Medical Care North America (FMCNA).
Fresenius Medical Care North America is a subsidiary of Fresenius Medical Care AG & Co. KGaA, the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1,770,000 individuals worldwide. Through its network of 2,448 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to approximately 187,476 patients around the globe. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS-p). |
|